|Bid||0.00 x 800|
|Ask||0.00 x 1300|
|Day's range||6.63 - 7.25|
|52-week range||3.39 - 8.03|
|Beta (5Y monthly)||N/A|
|PE ratio (TTM)||N/A|
|Earnings date||08 May 2023 - 12 May 2023|
|Forward dividend & yield||N/A (N/A)|
|1y target est||7.67|
The Zacks Medical - Services industry is growing on digital healthcare adoption. EMBC, INNV and OCX are set to gain the most. However, staffing shortages may disrupt the trend.
The heavy selling pressure might have exhausted for InnovAge Holding Corp. (INNV) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
InnovAge Names Christine Bent as Chief Operations Officer InnovAge Holding Corp. (“InnovAge”) (Nasdaq: INNV), an industry leader in providing comprehensive healthcare programs to frail dual-eligible seniors through the Program of All-inclusive Care for the Elderly (PACE), names Christine (Chris) Bent its Chief Operations Officer (COO) effective March 20, 2023. DENVER, March 01, 2023 (GLOBE NEWSWIRE) -- Today, InnovAge Holding Corp. (“InnovAge”) (Nasdaq: INNV), an industry leader in providing com